UnitedHealth (UNH) Raises Quarterly Dividend 5%, Bank of America Upgrades to Buy
UNH lifted its quarterly dividend to $2.32/share and earned a BofA upgrade to Buy — here's what both moves mean for UNH investors.
UnitedHealth Group Incorporated (NYSE: UNH) is a healthcare company, listed on the NYSE. Alpha Stocks Insight tracks UNH across all major catalysts: quarterly earnings reports, analyst upgrades and downgrades, mergers and acquisitions, regulatory decisions, and significant price moves driven by sector or macro developments. This page centralises 2 articles published since June 5, 2026, providing investors with timely, data-driven analysis of UnitedHealth Group Incorporated's financial performance and competitive position. New coverage is added each trading day.
A medical cost ratio drop to 86.7% drove UnitedHealth's 56% EPS beat and a 7% stock rally, as management raised full-year guidance across the board.
UNH lifted its quarterly dividend to $2.32/share and earned a BofA upgrade to Buy — here's what both moves mean for UNH investors.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.
Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.